HemoCue develops, produces and markets medical diagnostic products for point-of-care testing within hematology and diabetes.

HemoCue is a global leader in near-patient testing, working with healthcare professionals to identify, treat, and enhance patient care. Our systems and machines test 400,000 people daily across the globe.

The fundamental concept behind the HemoCue products is to perform important common blood tests that offer lab quality results at the Point of Care without sacrificing the accuracy and precision offered …

The HemoCue Glucose Systems put lab quality answers in health professionals’ hands when they’re needed most - at the point of care. Not only does the unique microcuvette technology enable …

The HemoCue® Glucose 201 DM system delivers high accuracy at the Point-of-Care through its diagnosis and monitoring of diabetes mellitus.

Pioneering point-of-care diagnostic testing since 1982, HemoCue’s diagnostic systems set the standard for accuracy and speed and are used to touch the lives of 400,000 people across the globe each day.

HemoCue has been a pioneer in point-of-care diagnostic testing since 1982. The company's diagnostic systems represent a standard for accuracy, speed and the best level of care that you can offer your …

Unlike conventional laboratory methods, which measure red and total blood cell counts; the HemoCue WBC System is a point-of-care device that provides quantitative results of a patient's white blood cell …

The specific steps below should be followed during every finger prick for hemoglobin screening using HemoCue. Step ___ACTION____________________________________________

The Hemocue device uses a method first described in 1960’s: modified azide-methemoglobin reaction. Sodium deoxycholate hemolyses erythrocytes and hemoglobin is released.